Biobots is the future of regenerative medicine – a high resolution desktop 3D bioprinter that builds functional three dimensional living tissue.

What is Bioprinting?

Bioprinting involves recreating the 3D structure of a tissue using a fabrication technique where a computer program slices up a construct into discrete layers and rebuilds them using some sort of biomaterial extruded from a printer head that can move up, down, and side-to-side. These biomaterials are designed to mimic the architecture of the extracellular matrix in which cells are suspended. Additionally, cells themselves can be incorporated into these constructs. So you can start imagining building a complex organ step-by-step using the 3D images, such as those from MRI and CT scans, native cells from a patient, and biologically compatible materials.



BioBots: Aiming to Democratize the Bioprinting World

Philadelphia-based start-up BioBots is aiming to shake up the human tissue engineering or “3D bioprinting” space by making its desktop 3D bioprinters available for only $5,000 to scientists, engineers, and medical professionals who qualify for its beta testing program.